MENU
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Halozyme Therapeutics (HALO) Ownership - Who owns Halozyme Therapeutics?
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.32B
P/E Ratio
17.27
Total Cash
596.07M
Projected Growth
N/A
Total Debt
1.51B
Revenue
1.02B
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash/Share
4.83
Total Debt/Equity
74.60
Revenue/Share
7.84 USD as % of share price
Fundamentals
HALO
Capitalization
7.32B
P/E Ratio
17.27
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash
596M
Total Cash/Share
4.83
Total Debt
1.51B
Total Debt/Equity
74.60
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.84%
Revenue
1.02B
ROE
N/A
Book Value
364M
P/B Ratio
20.12
Cash Flow
N/A
Earnings
3.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
123K
Current Ratio
7.80
Current Revenue Per Employee
851451.44
Dividends Per Share - Security
N/A
EBITDA
657M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.89
Revenue To Assets
23.39
Shares Held By Institutions
11.2B
Shares Outstanding - Current
124M
Total Liabilities
1.7B
Total Volume MTD
N/A
Value
-1
Gain YTD
23.928
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com